The title complex [Zn(C14H8N2O3Br2)(C5H5N)3] was synthesized in DMF and pyridine. It has been characterized by IR, element analysis and X-ray diffraction analysis. The crystal structure of the title complex belongs to...The title complex [Zn(C14H8N2O3Br2)(C5H5N)3] was synthesized in DMF and pyridine. It has been characterized by IR, element analysis and X-ray diffraction analysis. The crystal structure of the title complex belongs to monoclinic space group P21 / c with cell parameters: a=0.999 78(6) nm, b=1.951 11(13) nm, c=1.496 02(10) nm, β=97.126 0(10)°, and V=2.895 7(3) nm3, Dc=1.639 g·cm-3, Z=4, F(000)=1 424, μ=3.647 mm-1, the final R=0.061 0 and wR=0.140 2 for 3 528 observed reflections with I>2σ(I). The X-ray crystal structure analysis revealed that the center zinc(Ⅱ) is bonded to two oxygen atoms and one nitrogen atom from a tridentate ligand and three nitrogen atoms from three solvent pyridine molecules to form a six-coordinate octahedron. CCDC: 261047.展开更多
The new oxovanadium (V) complex, [PyH][VO2(L)] 1 (salicyladehyde 5-bromo salicyloylhydrazone is abbreviated as H2L; Hpy is protonated pyridine) was obtained from a refluxed solution of VOSO4 and H2L in acetonitrile-me...The new oxovanadium (V) complex, [PyH][VO2(L)] 1 (salicyladehyde 5-bromo salicyloylhydrazone is abbreviated as H2L; Hpy is protonated pyridine) was obtained from a refluxed solution of VOSO4 and H2L in acetonitrile-methanol-pyridine. Similarly, another new complex, [VO(L)(OCH3)] 2 was synthesized by refluxing VOSO4 and H2L in methanol-pyridine. Crystal data for 1: C19H15N3O5BrV, Mr= 496.2, monoclinic, P21/n, a = 7.1885(3), b = 9.2718(3), c = 28.803(1) A, β = 96.185(1)°, Z = 4 and V = 1908.6(1) A3; for 2: C15H12N2O5BrV, Mr= 431.1, monoclinic, P2,/n, a = 12.202(2), b = 8.045(2), c = 16.604(3) A, β = 101.29(3)°, Z = 4 and V = 1598.4(2) A3. The structures of 1 and 2 have been determined by X-ray analyses and reveal that the coordination environments of V atoms in both complexes are of square-based pyramid. Three of the four based donor atoms are from the tridentate 'ONO' donor ligand while the fourth is one terminal oxygen atom with the V(1) - O(3) distance 1.646(4) A for 1 and one -OCH3 group with the V(1)-O(3) distance 1.753(3) A for 2. The V(1)-O(4) terminals occupy the axial sites in both cases. The complexes are also characterized by IR and 1H NMR spectroscopies.展开更多
文摘The title complex [Zn(C14H8N2O3Br2)(C5H5N)3] was synthesized in DMF and pyridine. It has been characterized by IR, element analysis and X-ray diffraction analysis. The crystal structure of the title complex belongs to monoclinic space group P21 / c with cell parameters: a=0.999 78(6) nm, b=1.951 11(13) nm, c=1.496 02(10) nm, β=97.126 0(10)°, and V=2.895 7(3) nm3, Dc=1.639 g·cm-3, Z=4, F(000)=1 424, μ=3.647 mm-1, the final R=0.061 0 and wR=0.140 2 for 3 528 observed reflections with I>2σ(I). The X-ray crystal structure analysis revealed that the center zinc(Ⅱ) is bonded to two oxygen atoms and one nitrogen atom from a tridentate ligand and three nitrogen atoms from three solvent pyridine molecules to form a six-coordinate octahedron. CCDC: 261047.
基金The work was supported by the Chinese Academy of Sciences, the National Natural Science Foundation of China(20073048)the NSF of Fujian province for financial support
文摘The new oxovanadium (V) complex, [PyH][VO2(L)] 1 (salicyladehyde 5-bromo salicyloylhydrazone is abbreviated as H2L; Hpy is protonated pyridine) was obtained from a refluxed solution of VOSO4 and H2L in acetonitrile-methanol-pyridine. Similarly, another new complex, [VO(L)(OCH3)] 2 was synthesized by refluxing VOSO4 and H2L in methanol-pyridine. Crystal data for 1: C19H15N3O5BrV, Mr= 496.2, monoclinic, P21/n, a = 7.1885(3), b = 9.2718(3), c = 28.803(1) A, β = 96.185(1)°, Z = 4 and V = 1908.6(1) A3; for 2: C15H12N2O5BrV, Mr= 431.1, monoclinic, P2,/n, a = 12.202(2), b = 8.045(2), c = 16.604(3) A, β = 101.29(3)°, Z = 4 and V = 1598.4(2) A3. The structures of 1 and 2 have been determined by X-ray analyses and reveal that the coordination environments of V atoms in both complexes are of square-based pyramid. Three of the four based donor atoms are from the tridentate 'ONO' donor ligand while the fourth is one terminal oxygen atom with the V(1) - O(3) distance 1.646(4) A for 1 and one -OCH3 group with the V(1)-O(3) distance 1.753(3) A for 2. The V(1)-O(4) terminals occupy the axial sites in both cases. The complexes are also characterized by IR and 1H NMR spectroscopies.
